Aurinia Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AUPH research report →
About the company
Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally.
- CEO
- Kevin C. Tang
- IPO
- 2014
- Employees
- 130
- HQ
- Edmonton, BC, CA
Price Chart
- Market Cap
- $2.01B
- P/E
- 6.93
- P/S
- 6.73
- P/B
- 3.64
- EV/EBITDA
- 12.58
- Div Yield
- 0.00%
- Gross Margin
- 89.74%
- Op Margin
- 41.73%
- Net Margin
- 99.97%
- ROE
- 64.48%
- ROIC
- 18.99%
- Revenue
- $283.06M · 20.38%
- Net Income
- $287.20M · 4893.08%
- EPS
- $2.14 · 5250.00%
- Op Income
- $104.91M
- FCF YoY
- 206.99%
- 52W High
- $19.25
- 52W Low
- $7.36
- 50D MA
- $15.99
- 200D MA
- $14.79
- Beta
- 1.42
- Avg Volume
- 1.43M
Get TickerSpark's AI analysis on AUPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Johnson Craig A | other | 23,931 |
| Jun 4, 26 | Goetz Kathleen | other | 23,931 |
| Jun 4, 26 | Nova Tina Susan | other | 23,931 |
| Jun 4, 26 | Bailey Jeffrey Allen | other | 23,931 |
| Jun 2, 26 | TANG KEVIN | buy | 206,005 |
| Jun 1, 26 | TANG KEVIN | buy | 99 |
| Jun 1, 26 | TANG KEVIN | buy | 343,521 |
| May 29, 26 | TANG KEVIN | buy | 262,682 |
| May 29, 26 | TANG KEVIN | buy | 2,299 |
| Jun 2, 26 | TANG KEVIN | other | 10,000 |
Our AUPH coverage
Recent articles, reports, and earnings notes.
No research on AUPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AUPH report →Similar companies
Peers in the same neighborhood.